Gareth Powell, Co-Head of Healthcare at Polar Capital, looks at how the companies operating in healthcare reacted to the pandemic, from pushing the boundaries to speed up Research & Development (R&D), to being able to produce and deliver a supply of the vaccine to those who most needed it first. He acknowledges that coronavirus is likely to be around for a good while yet so also touches on how the industry needs to learn from this and develop in the future.